R J S D Heine (Renaud Heine)

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Venues

Circulation. Cardiovascular quality and outcomes

PloS one

Cancers

Health economics

Erasmus School of Health Policy and Management

Erasmus Universiteit Rotterdam (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Erasmus School of Health Policy and Management Mar 01 2019

Netherlands

Phd candidate :: Health Technology Assessment

Education History

Erasmus Universiteit Rotterdam Sep 01 2018 - Sep 01 2019

Netherlands

MSC :: ESHPM

Erasmus Universiteit Rotterdam Sep 01 2017 - Sep 01 2018

Netherlands

MSC

Publications

R J S D Heine, F W Thielen, R H J Mathijssen, R W F van Leeuwen, M G Franken, C A Uyl-de Groot
Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumab. PloS one 19 (2) (2024)
Hannah Lu, Laura Anne Hatfield, Saeed Al-Azazi, Pieter L H Bakx, Amitava Banerjee, Nitzan Burrack, Yu-Chin Chen, Christina Fu, Michal Gordon, R J S D Heine, Nicole Huang, Dennis T Ko, Lisa M Lix, Victor Novack, Laura Pasea, Feng Qiu, Therese A Stukel, Carin Uyl-de Groot, Gabe Weinreb, Bruce E Landon, Peter Cram
Sex-Based Disparities in Acute Myocardial Infarction Treatment Patterns and Outcomes in Older Adults Hospitalized Across 6 High-Income Countries: An Analysis From the International Health Systems Research Collaborative. Circulation. Cardiovascular quality and outcomes 17 (3) (2024)
R J S D Heine, F W Thielen, R H J Mathijssen, R W F van Leeuwen, M G Franken, C A Uyl-de Groot
Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumab. PloS one 19 (2) (2024)
R J S D Heine, F W Thielen, R H J Mathijssen, R W F van Leeuwen, M G Franken, C A Uyl-de Groot
Applying a cost-based pricing model for innovative cancer treatments subject to indication expansion: A case study for pembrolizumab and daratumumab. PloS one 19 (2) (2024)
Hannah Lu, Laura Anne Hatfield, Saeed Al-Azazi, Pieter L H Bakx, Amitava Banerjee, Nitzan Burrack, Yu-Chin Chen, Christina Fu, Michal Gordon, R J S D Heine, Nicole Huang, Dennis T Ko, Lisa M Lix, Victor Novack, Laura Pasea, Feng Qiu, Therese A Stukel, Carin Uyl-de Groot, Gabe Weinreb, Bruce E Landon, Peter Cram
Sex-Based Disparities in Acute Myocardial Infarction Treatment Patterns and Outcomes in Older Adults Hospitalized Across 6 High-Income Countries: An Analysis From the International Health Systems Research Collaborative. Circulation. Cardiovascular quality and outcomes (2024)
Hannah Lu, Laura Anne Hatfield, Saeed Al-Azazi, Pieter L H Bakx, Amitava Banerjee, Nitzan Burrack, Yu-Chin Chen, Christina Fu, Michal Gordon, R J S D Heine, Nicole Huang, Dennis T Ko, Lisa M Lix, Victor Novack, Laura Pasea, Feng Qiu, Therese A Stukel, Carin Uyl-de Groot, Gabe Weinreb, Bruce E Landon, Peter Cram
Sex-Based Disparities in Acute Myocardial Infarction Treatment Patterns and Outcomes in Older Adults Hospitalized Across 6 High-Income Countries: An Analysis From the International Health Systems Research Collaborative. Circulation. Cardiovascular quality and outcomes 17 (3) (2024)
Hannah Lu, Laura Anne Hatfield, Saeed Al-Azazi, Pieter L H Bakx, Amitava Banerjee, Nitzan Burrack, Yu-Chin Chen, Christina Fu, Michal Gordon, R J S D Heine, Nicole Huang, Dennis T Ko, Lisa M Lix, Victor Novack, Laura Pasea, Feng Qiu, Therese A Stukel, Carin Uyl-de Groot, Gabe Weinreb, Bruce E Landon, Peter Cram
Sex-Based Disparities in Acute Myocardial Infarction Treatment Patterns and Outcomes in Older Adults Hospitalized Across 6 High-Income Countries: An Analysis From the International Health Systems Research Collaborative. Circulation. Cardiovascular quality and outcomes 17 (3) (2024)
Stefan Rabbe, Meilin Möllenkamp, Benedetta Pongiglione, Hedwig M Blommestein, Pim Wetzelaer, R J S D Heine, Jonas Schreyögg
Variation in the utilization of medical devices across Germany, Italy, and the Netherlands: A multilevel approach. Health economics (2022)
Carin A Uyl-de Groot, R J S D Heine, Marieke Krol, Jaap Verweij
Unequal Access to Newly Registered Cancer Drugs Leads to Potential Loss of Life-Years in Europe. Cancers 12 (8) (2020)

R J S D Heine.css-eqlu8i{font-size:small;padding-left:4px;} (Renaud Heine)

Publication Activity (10 Years)

Top Topics

Top Venues

R J S D Heine (Renaud Heine)